Rockland Trust’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Hold
425
0.01% 303
2026
Q1
$239K Hold
425
0.01% 293
2025
Q4
$288K Buy
425
+18
+4% +$12.3K 0.01% 269
2025
Q3
$260K Buy
407
+7
+2% +$4.25K 0.01% 271
2025
Q2
$215K Buy
+400
New +$191K 0.01% 250
2024
Q4
Sell
-400
Closed -$202K 288
2024
Q3
$202K Buy
+400
New +$194K 0.01% 278
2024
Q2
Sell
-400
Closed -$216K 300
2024
Q1
$216K Sell
400
-140
-26% -$76.5K 0.01% 281
2023
Q4
$300K Hold
540
0.02% 251
2023
Q3
$236K Buy
540
+70
+15% +$34.9K 0.01% 265
2023
Q2
$236K Hold
470
0.01% 268
2023
Q1
$235K Buy
+470
New +$225K 0.01% 268
2022
Q2
Sell
-470
Closed -$257K 306
2022
Q1
$257K Hold
470
0.02% 282
2021
Q4
$309K Hold
470
0.02% 251
2021
Q3
$293K Hold
470
0.02% 244
2021
Q2
$297K Buy
470
+50
+12% +$27.6K 0.02% 236
2021
Q1
$205K Hold
420
0.01% 264
2020
Q4
$210K Buy
+420
New +$188K 0.02% 247

Other funds holding IDXX

Rockland Trust's IDXX Position: Q2 2026 in Review

Rockland Trust held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 425 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #303.

Rockland Trust first reported a position in IDXX in Q4 2020 and has held it in 17 quarters since. The position peaked at $309K in Q4 2021. 557 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Rockland Trust held 425 shares of Idexx Laboratories worth $224K as of Q2 2026.
  • Rockland Trust left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up 0.01% of Rockland Trust's portfolio in Q2 2026, its #303 holding.
  • Rockland Trust first reported a position in Idexx Laboratories in Q4 2020 and has held it in 17 quarters since.
  • Rockland Trust's Idexx Laboratories position peaked at $309K in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Rockland Trust's 13F filing for Q2 2026, filed 8 Jul 2026.